---
title: "300238.SZ (300238.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300238.SZ/news.md"
symbol: "300238.SZ"
name: "300238.SZ"
parent: "https://longbridge.com/en/quote/300238.SZ.md"
datetime: "2026-05-21T03:25:20.003Z"
locales:
  - [en](https://longbridge.com/en/quote/300238.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300238.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300238.SZ/news.md)
---

# 300238.SZ (300238.SZ) — Related News

### [Guanhao Biotech: Net profit in the first quarter was 10.1623 million yuan, a year-on-year decrease of 31.64%](https://longbridge.com/en/news/284387598.md)
*2026-04-28T12:35:00.000Z*
> Guanhao Biotech announced that the revenue for the first quarter was 93.444 million yuan, a year-on-year decrease of 1.4

### [](https://longbridge.com/en/news/281819626.md)
*2026-04-07T02:16:54.000Z*
> The A-share medical consumables concept experienced fluctuations and surged during the trading session, with INTCO risin

### [Guanhao Biotech released its 2025 annual performance, with a net profit attributable to the parent company of 24.346 million yuan, a decrease of 11.20%](https://longbridge.com/en/news/280459105.md)
*2026-03-25T10:57:05.000Z*
> Guanhao Biotech released its 2025 annual report, with operating revenue of 388 million yuan, a year-on-year increase of 

### [Guanhao Biotech: Revenue of 388 million yuan in 2025, net profit down 11.20% year-on-year](https://longbridge.com/en/news/280454878.md)
*2026-03-25T10:26:43.000Z*
> Guanhao Biotech announced that in 2025, the company's operating revenue will be 388 million yuan, a year-on-year increas

### [HuaGuan Biotech completes hundreds of millions in Series C financing, committed to synthetic biology and green chemical production](https://longbridge.com/en/news/274738512.md)
*2026-02-04T01:34:07.000Z*
> Beijing Huaguan Biotechnology Co., Ltd. has completed a C round financing of several hundred million RMB, with investors

### [Guanhao Biotech: The company has not yet collaborated with Qiangnao Technology](https://longbridge.com/en/news/272798724.md)
*2026-01-16T07:26:07.000Z*
> On January 16th, Guanhao Biotech stated on the interactive platform that the company has not yet cooperated with Qiangna

### [Breakthrough in Thymus Regeneration of Mexican Axolotl! A-share Regenerative Medicine Concept Stocks May Welcome Explosive Opportunities!](https://longbridge.com/en/news/268911198.md)
*2025-12-08T07:26:15.000Z*
> Chinese scientists collaborated with a U.S. team to prove for the first time that the thymus of the Mexican axolotl can 

### [](https://longbridge.com/en/news/265450807.md)
*2025-11-12T06:38:42.000Z*
> The concept of innovative drugs continues to be active, with Zhongsheng Pharmaceutical hitting the daily limit, and Jimi